Medical Intellectual Property Market by Type (Patents, Trademarks, Copyrights, Others); by Application (Orthopedic, Dental, Others); by Regional Outlook (U.S., France, UK, Germany, Spain, Italy, Rest of Europe) – U.S. and Europe Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2018 - 2026

Report ID :AMI-124 | Category : Healthcare | Published Date :August, 2018 | Pages : 397 | Format :PDF
Buy Now!

Industry Trends

Intellectual property rights have various forms in medical industry wherein patents are considered as one of the important form. Intellectual property is the property which is intangible i.e. which don’t have any physical form. Patents in this industry gives competitive advantage owing to monopoly features. The formula used in manufacturing and developing of drugs can be easily duplicated or drugs can be synthesized at cheaper cost, in such cases importance of intellectual property rights is more. Patent protection is heavily utilized by pharmaceutical companies moreover, trademarks are another intellectual property right used by companies to identify their products. The U.S. medical intellectual property market, in terms of revenue, was valued at US$ 8,656.0 Bn in 2017 and is expected to reach US$ 10,095.0 Bn by 2022.

U.S. Medical Intellectual Property Market, By Type, 2017 & 2022 (USD Billion)

Medical Intellectual Property Market

Intellectual property right provides protection to innovations, ideas or other intangible assets for specific period of time. In such cases person need not to worry about the competition in the market.  Patents in the type segment has the largest market share, accounting for US$ 5,643.35 Bn in 2017 in the United States. It has been reported that, 65% of innovations in pharmaceutical would not have been possible without patents. The firms in this region invest heavily in research & development activities and temporary monopoly in medical intellectual property rights helps them to recover this cost.

For extremely simple innovation, attorney fees for filing in the United States ranges between US$ 5,000 to 7,000. High costs of copyrights and licenses can critically impact the market; however, the impact of such costs reduces owing to rising popularity in forthcoming period.

Small and medium enterprises, high growth companies, startups and universities are expected to represent many opportunities in the next few years. These organizations play a crucial role in development of various products in pharmaceutical, medical device and biotech industry. They also have huge potential in the medical intellectual property market, owing to the huge amount of funding they are receiving in from many investors.

Medical Intellectual Property Market, By Region

The United States in this industry accounted for US$ 8,656.0 Bn in 2017. The overall U.S. market registered 8,656 filings in the 2017. Major of the pharmaceutical and medical device manufacturers have their research and development centers in various states of the U.S. The focus on R&D coupled with innovation-centric technologies are driving the demand in this region.

Competitive Market Share

The report provides both, qualitative and quantitative research of the market, as well as it helps to gain important insights of current and future market and trending technologies adopted by the key players. The medical intellectual property market report also offers extensive research on the key players in this market and detailed insights on the competitiveness of these players. The key business strategies such as mergers and acquisitions(M&A), affiliations, collaborations, and contracts adopted by the major players are also recognized and analyzed in the report. For each company, the report recognizes their manufacturing base, competitors, product type, application and specification, pricing, and gross margin.

Key participants of global medical intellectual property market are White & Case LLP, Al Tamimi & Company, Quinn Emanuel Urquhart & Sullivan, LLP, WilmerHale, Irell & Manella LLP, Baker McKenzie LLP, Powell Gilbert LLP, Bristows LLP, Bird & Bird, Herbert Smith Freehills LLP and Morrison & Foerster LLP amongst others.

 Medical Intellectual Property Industry Background

Skin Substitutes Market

Skin Substitutes Market

1.    Introduction

1.1.   Market Scope

1.2.   Market Segmentation

1.3.   Methodology

1.4.   Assumptions

2.    Medical Intellectual Property Market Snapshot

3.    Executive Summary: Medical Intellectual Property Market

4.    Qualitative Analysis: Medical Intellectual Property Market

4.1.   Introduction

4.1.1.   Product Definition

4.1.2.   Industry Development

4.2.   Market Dynamics

4.2.1.   Drivers

4.2.2.   Restraints

4.2.3.   Opportunities

4.3.   Trends in Market

5.    U.S. Medical Intellectual Property Market Analysis and Forecasts, 2018 – 2026

5.1.   U.S.

5.1.1.   U.S. Market Revenue (US$ Bn)

5.2.   U.S. Medical Intellectual Property Market Revenue (US$ Bn) and Forecasts, By Type

5.2.1.1.    Patents

5.2.1.2.    Trademarks

5.2.1.3.    Copyrights

5.2.1.4.    Others (trade dress and trade secrets)

5.3.   U.S. Medical Intellectual Property Market Revenue (US$ Bn) and Forecasts, By Application

5.3.1.1.    Orthopedic

5.3.1.2.    Dental

5.3.1.3.    Others

6.    Europe Medical Intellectual Property Market Analysis and Forecasts, 2018 – 2026

6.1.   Overview

6.1.1.   Europe Market Revenue (US$ Bn)

6.2.   Europe Medical Intellectual Property Market Revenue (US$ Bn) and Forecasts, By Type

6.2.1.   Patents

6.2.2.   Trademarks

6.2.3.   Copyrights

6.2.4.   Others (trade dress and trade secrets)

6.3.   Europe Medical Intellectual Property Market Revenue (US$ Bn) and Forecasts, By Application

6.3.1.   Orthopedic

6.3.2.   Dental

6.3.3.   Others

6.4.   Europe Market Revenue (US$ Bn) and Forecasts, By Country

6.4.1.   France

6.4.1.1.    France Medical Intellectual Property Market Revenue (US$ Bn) and Forecasts, By Type

6.4.1.1.1.    Patents

6.4.1.1.2.    Trademarks

6.4.1.1.3.    Copyrights

6.4.1.1.4.    Others (trade dress and trade secrets)

6.4.1.2.    France Medical Intellectual Property Market Revenue (US$ Bn) and Forecasts, By Application

6.4.1.2.1.    Orthopedic

6.4.1.2.2.    Dental

6.4.1.2.3.    Others

6.4.2.   The UK

6.4.2.1.    The UK Medical Intellectual Property Market Revenue (US$ Bn) and Forecasts, By Type

6.4.2.1.1.    Patents

6.4.2.1.2.    Trademarks

6.4.2.1.3.    Copyrights

6.4.2.1.4.    Others (trade dress and trade secrets)

6.4.2.2.    The UK Medical Intellectual Property Market Revenue (US$ Bn) and Forecasts, By Application

6.4.2.2.1.    Orthopedic

6.4.2.2.2.    Dental

6.4.2.2.3.    Others

6.4.3.   Spain

6.4.3.1.    Spain Medical Intellectual Property Market Revenue (US$ Bn) and Forecasts, By Type

6.4.3.1.1.    Patents

6.4.3.1.2.    Trademarks

6.4.3.1.3.    Copyrights

6.4.3.1.4.    Others (trade dress and trade secrets)

6.4.3.2.    Spain Medical Intellectual Property Market Revenue (US$ Bn) and Forecasts, By Application

6.4.3.2.1.    Orthopedic

6.4.3.2.2.    Dental

6.4.3.2.3.    Others

6.4.4.   Germany

6.4.4.1.    Germany Medical Intellectual Property Market Revenue (US$ Bn) and Forecasts, By Type

6.4.4.1.1.    Patents

6.4.4.1.2.    Trademarks

6.4.4.1.3.    Copyrights

6.4.4.1.4.    Others (trade dress and trade secrets)

6.4.4.2.    Germany Medical Intellectual Property Market Revenue (US$ Bn) and Forecasts, By Application

6.4.4.2.1.    Orthopedic

6.4.4.2.2.    Dental

6.4.4.2.3.    Others

6.4.5.   Italy

6.4.5.1.    Italy Medical Intellectual Property Market Revenue (US$ Bn) and Forecasts, By Type

6.4.5.1.1.    Patents

6.4.5.1.2.    Trademarks

6.4.5.1.3.    Copyrights

6.4.5.1.4.    Others (trade dress and trade secrets)

6.4.5.2.    Italy Medical Intellectual Property Market Revenue (US$ Bn) and Forecasts, By Application

6.4.5.2.1.    Orthopedic

6.4.5.2.2.    Dental

6.4.5.2.3.    Others

6.4.6.   Rest of Europe

6.4.6.1.    Rest of Europe Medical Intellectual Property Market Revenue (US$ Bn) and Forecasts, By Type

6.4.6.1.1.    Patents

6.4.6.1.2.    Trademarks

6.4.6.1.3.    Copyrights

6.4.6.1.4.    Others (trade dress and trade secrets)

6.4.6.2.    Rest of Europe Medical Intellectual Property Market Revenue (US$ Bn) and Forecasts, By Application

6.4.6.2.1.    Orthopedic

6.4.6.2.2.    Dental

6.4.6.2.3.    Others

6.5.   Key Segment for Channeling Investments

6.5.1.   By Country

6.5.2.   By Type

6.5.3.   By Application

7.    Competitive Benchmarking

7.1.   Player Positioning Analysis

7.2.   U.S and Europe Presence and Growth Strategies

8.    Player Profiles

8.1.   Morrison & Foerster LLP.

8.1.1.   Company Details

8.1.2.   Company Overview

8.1.3.   Product Offerings

8.1.4.   Key Developments

8.1.5.   Financial Analysis

8.1.6.   SWOT Analysis

8.1.7.   Business Strategies

8.2.   Herbert Smith Freehills LLP

8.2.1.   Company Details

8.2.2.   Company Overview

8.2.3.   Product Offerings

8.2.4.   Key Developments

8.2.5.   Financial Analysis

8.2.6.   SWOT Analysis

8.2.7.   Business Strategies

8.3.   Bird & Bird

8.3.1.   Company Details

8.3.2.   Company Overview

8.3.3.   Product Offerings

8.3.4.   Key Developments

8.3.5.   Financial Analysis

8.3.6.   SWOT Analysis

8.3.7.   Business Strategies

8.4.   Bristows LLP

8.4.1.   Company Details

8.4.2.   Company Overview

8.4.3.   Product Offerings

8.4.4.   Key Developments

8.4.5.   Financial Analysis

8.4.6.   SWOT Analysis

8.4.7.   Business Strategies

8.5.   Powell Gilbert LLP

8.5.1.   Company Details

8.5.2.   Company Overview

8.5.3.   Product Offerings

8.5.4.   Key Developments

8.5.5.   Financial Analysis

8.5.6.   SWOT Analysis

8.5.7.   Business Strategies

8.6.   Baker McKenzie LLP

8.6.1.   Company Details

8.6.2.   Company Overview

8.6.3.   Product Offerings

8.6.4.   Key Developments

8.6.5.   Financial Analysis

8.6.6.   SWOT Analysis

8.6.7.   Business Strategies

8.7.   Irell & Manella LLP

8.7.1.   Company Details

8.7.2.   Company Overview

8.7.3.   Product Offerings

8.7.4.   Key Developments

8.7.5.   Financial Analysis

8.7.6.   SWOT Analysis

8.7.7.   Business Strategies

8.8.   WilmerHale

8.8.1.   Company Details

8.8.2.   Company Overview

8.8.3.   Product Offerings

8.8.4.   Key Developments

8.8.5.   Financial Analysis

8.8.6.   SWOT Analysis

8.8.7.   Business Strategies

8.9.   Quinn Emanuel Urquhart & Sullivan, LLP

8.9.1.   Company Details

8.9.2.   Company Overview

8.9.3.   Product Offerings

8.9.4.   Key Developments

8.9.5.   Financial Analysis

8.9.6.   SWOT Analysis

8.9.7.   Business Strategies

8.10. Al Tamimi & Company

8.10.1. Company Details

8.10.2. Company Overview

8.10.3. Product Offerings

8.10.4. Key Developments

8.10.5. Financial Analysis

8.10.6. SWOT Analysis

8.10.7. Business Strategies

8.11. White & Case LLP

8.11.1. Company Details

8.11.2. Company Overview

8.11.3. Product Offerings

8.11.4. Key Developments

8.11.5. Financial Analysis

8.11.6. SWOT Analysis

8.11.7. Business Strategies

 

 

 Note: This ToC is tentative and can be changed according to the research study conducted during the course of report completion.

At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.   

Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.  

Prominent participants in our primary research process include:

  • Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
  • Research and development participants, distributors/suppliers and subject matter experts

Secondary Research includes data extracted from paid data sources:

  • Reuters
  • Factiva
  • Bloomberg
  • One Source
  • Hoovers

 

Research Methodology

Methodology

Key Inclusions

Methodology

  • A PHP Error was encountered

    Severity: Notice

    Message: Undefined offset: 0

    Filename: pages/reportpage.php

    Line Number: 204

    Backtrace:

    File: /home/absolute/public_html/application/views/pages/reportpage.php
    Line: 204
    Function: _error_handler

    File: /home/absolute/public_html/application/controllers/Report.php
    Line: 153
    Function: view

    File: /home/absolute/public_html/index.php
    Line: 315
    Function: require_once